jueves, 4 de septiembre de 2025

CDER/CBER Rare Disease Evidence Principles (RDEP) A proposed process to facilitate the approval of drugs to treat rare diseases

https://www.fda.gov/industry/fda-rare-disease-innovation-hub/cdercber-rare-disease-evidence-principles-rdep

No hay comentarios:

Publicar un comentario